NIH Study Finds Low-Intensity Therapy For Burkitt Lymphoma Is Highly Effective RedOrbit Nineteen HIV-negative patients received dose-adjusted (DA)-EPOCH-R, whereas 11 HIV-positive patients received SC-EPOCH-RR, which is a short-course (SC) variant of EPOCH-R that includes two doses of rituximab per treatment cycle and has a lower ... Low-Intensity Chemo Highly Effective in Burkitt Lymphoma |
